Sign in

CIK 0001690585 · Non-accelerated filer<br>Smaller reporting company

Dianthus Therapeutics, Inc. /DE/

Sign in to watch
Ticker
DNTH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
929-999-4055
Business address
7 TIMES SQUARE, 43RD FLOOR, NEW YORK, NY, 10036
Former names
Magenta Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$16,043,610
in 4 filings, $16.0M under 10b5-1 plans

Net −$16,043,610. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Savitz Ryan −$11.2M EVP, CFO & CBO sold 100% of stake
  2. Randhawa Simrat −$2.5M EVP, Head of R&D sold 85% of stake
  3. CARR EDWARD −$2.0M CHIEF ACCOUNTING OFFICER sold 100% of stake
  4. Read Simon −$327K Director sold 100% of stake
Date Insider Transaction Shares Price Value Owned after
2019-12-02 COOKE MICHAEL P. Chief Scientific Officer Sale −1,373 $13.31 $18K 243,023
2019-12-02 COOKE MICHAEL P. Chief Scientific Officer Sale −2,500 $13.21 $33K 240,523
2019-11-20 COOKE MICHAEL P. Chief Scientific Officer Sale −5,000 $12.00 $60K 248,023
2019-11-01 COOKE MICHAEL P. Chief Scientific Officer Sale −5,000 $10.67 $53K 253,023
2019-10-01 COOKE MICHAEL P. Chief Scientific Officer Sale −5,000 $10.01 $50K 258,023
2019-09-19 COOKE MICHAEL P. Chief Scientific Officer Sale −1,656 $12.00 $20K 263,023
2019-09-12 COOKE MICHAEL P. Chief Scientific Officer Sale −844 $12.00 $10K 264,679
2019-09-03 COOKE MICHAEL P. Chief Scientific Officer Sale −5,000 $10.11 $51K 265,523
2019-08-01 COOKE MICHAEL P. Chief Scientific Officer Sale −5,000 $13.42 $67K 273,023
2019-08-01 COOKE MICHAEL P. Chief Scientific Officer Sale −2,500 $13.41 $34K 270,523
2019-07-01 COOKE MICHAEL P. Chief Scientific Officer Sale −5,000 $14.39 $72K 280,523
2019-07-01 COOKE MICHAEL P. Chief Scientific Officer Sale −2,500 $14.42 $36K 278,023
2019-06-21 ISACSON CHRISTINA K. Chief Business Officer Sale −5,415 $16.07 $87K 98,116
2019-06-21 GARDNER JASON See Remarks Sale −12,331 $15.11 $186K 349,212
2019-06-20 GARDNER JASON See Remarks Sale −1,669 $15.10 $25K 361,543
2019-06-20 McGeorge Anne Director Grant or award · Stock Option (Right to Buy) +36,377 36,377
2019-06-17 COOKE MICHAEL P. Chief Scientific Officer Sale −7,500 $13.90 $104K 285,523
2019-06-07 Albers Jeffrey W. Director Grant or award · Stock Option (Right to Buy) +18,188 18,188
2019-06-07 RONNEBERG AMY L Director Grant or award · Stock Option (Right to Buy) +18,188 18,188
2019-06-07 Scadden David Director Grant or award · Stock Option (Right to Buy) +18,188 18,188

Page 20 of 24 · 470 trades